These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9280748)

  • 1. [Heart failure patients are often on the verge of decompensation. Methods for reliable management in general practice].
    Dotzer F
    Fortschr Med; 1997 Jun; 115(16):46-7. PubMed ID: 9280748
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacologic treatment of heart failure.
    Nagelhout JJ
    Nurs Clin North Am; 1991 Jun; 26(2):401-15. PubMed ID: 2047289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of inotropic drugs in clinical practice.
    Smith TW
    Eur Heart J; 1982 Dec; 3 Suppl D():149-56. PubMed ID: 6130948
    [No Abstract]   [Full Text] [Related]  

  • 4. [Are cardiac glycosides still needed in the treatment of cardiac insufficiency?].
    Böhm M
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2133-8. PubMed ID: 12397560
    [No Abstract]   [Full Text] [Related]  

  • 5. [Heart failure - a scientific and clinical challenge].
    Hasenfuss G; Erdmann E
    Dtsch Med Wochenschr; 2011 Apr; 136(16):809. PubMed ID: 21487969
    [No Abstract]   [Full Text] [Related]  

  • 6. [Peculiarities of cardiac glycoside therapy in the aged].
    Erdmann E
    Internist (Berl); 1991 Aug; 32(8):472-8. PubMed ID: 1938268
    [No Abstract]   [Full Text] [Related]  

  • 7. Guidelines abstracted from consensus recommendations for the management of chronic heart failure.
    J Am Geriatr Soc; 2000 Nov; 48(11):1521-4. PubMed ID: 11083336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pre-, intra- and postoperative heart failure: diagnosis, treatment strategies and control of effectiveness].
    Kromer EP
    Klin Anasthesiol Intensivther; 1995; 47():61-75. PubMed ID: 7715180
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac glycosides in the next millennium.
    Hauptman PJ; Garg R; Kelly RA
    Prog Cardiovasc Dis; 1999; 41(4):247-54. PubMed ID: 10362347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of refractory cardiac insufficiency by peritoneal ultrafiltration. Literature review].
    Lécluse E; Ryckelink JP; Lobbedez T; Saloux E; Duarte C; Devaluez F; Hurault de Ligny BH; Valette B; Hamon M; Grollier G; Potier JC
    Ann Cardiol Angeiol (Paris); 1999 Jan; 48(1):32-6. PubMed ID: 12555356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute decompensated heart failure.
    Neuenschwander JF; Baliga RR
    Crit Care Clin; 2007 Oct; 23(4):737-58, vi. PubMed ID: 17964361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current data on the role of cardiac glycosides in the treatment of circulatory insufficiency].
    Valenkevich LN; Lemkina SM
    Klin Med (Mosk); 1989 Jan; 67(1):18-23. PubMed ID: 2654460
    [No Abstract]   [Full Text] [Related]  

  • 13. [New positive inotropic drugs].
    Pfaffendorf M
    Med Monatsschr Pharm; 1997 Aug; 20(8):205-17. PubMed ID: 9340466
    [No Abstract]   [Full Text] [Related]  

  • 14. Inotropes in the management of acute heart failure.
    Petersen JW; Felker GM
    Crit Care Med; 2008 Jan; 36(1 Suppl):S106-11. PubMed ID: 18158469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comprehensive indication for glycoside therapy from the neurologic-phychiatric viewpoint].
    Diehl LW
    Ther Ggw; 1975 Mar; 114(3):336, 338-40 342-4 PASSIM. PubMed ID: 1092026
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of calcium pantothenate on the cardiotonic effect of cardiac glycosides].
    Masliuk VI; Polosova TA; Litvintsev VP
    Sov Med; 1980; (4):21-3. PubMed ID: 7384876
    [No Abstract]   [Full Text] [Related]  

  • 17. [1st national guideline for chronic heart failure. Essential responsibilities for the family practitioner].
    Aumiller J
    MMW Fortschr Med; 2010 Apr; 152(14):12-4. PubMed ID: 20614740
    [No Abstract]   [Full Text] [Related]  

  • 18. Patient differences related to management in general practice and the hospital: a cross-sectional study of heart failure in the community.
    Nielsen OW; McDonagh T; Cowburn P; Blue L; Robb SD; Dargie H
    Eur Heart J; 2004 Oct; 25(19):1718-25. PubMed ID: 15451150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure.
    Liu P; Arnold M; Belenkie I; Howlett J; Huckell V; Ignazewski A; LeBlanc MH; McKelvie R; Niznick J; Parker JD; Rao V; Ross H; Roy D; Smith S; Sussex B; Teo K; Tsuyuki R; White M; Beanlands D; Bernstein V; Davies R; Issac D; Johnstone D; Lee H; Moe G; Newton G; Pflugfelder P; Roth S; Rouleau J; Yusuf S;
    Can J Cardiol; 2001 Dec; 17 Suppl E():5E-25E. PubMed ID: 11773943
    [No Abstract]   [Full Text] [Related]  

  • 20. Heart failure: metabolic derangements and therapeutic rationale.
    Gebreegziabher Y; Makaryus AN; Makaryus JN; McFarlane SI
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):331-43. PubMed ID: 17338676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.